Phillip Monk
Director Técnico/Científico/I+D en SYNAIRGEN PLC .
Fortuna: 32 910 $ al 30/04/2024
Perfil
Phillip David Monk is currently the Executive Director & Chief Scientific Officer at Synairgen Plc since 2009.
He is also currently a Director at Synairgen Research Ltd.
Additionally, he previously worked as the Director-Respiratory & Inflammation Biology Group at MedImmune Ltd.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SYNAIRGEN PLC
0.21% | 31/12/2022 | 423 934 ( 0.21% ) | 32 910 $ | 30/04/2024 |
Cargos activos de Phillip Monk
| Empresas | Cargo | Inicio |
|---|---|---|
| SYNAIRGEN PLC | Director Técnico/Científico/I+D | 03/09/2009 |
Synairgen Research Ltd.
 Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The company is based in Southampton, UK. Synairgen Research was founded in 2003. | Director/Miembro de la Junta | 03/09/2009 |
Antiguos cargos conocidos de Phillip Monk.
| Empresas | Cargo | Fin |
|---|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SYNAIRGEN PLC | Health Technology |
| Empresas privadas | 2 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Synairgen Research Ltd.
Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The company is based in Southampton, UK. Synairgen Research was founded in 2003. | Commercial Services |
- Bolsa de valores
- Insiders
- Phillip Monk
